{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T17:49:43Z","timestamp":1791049783777,"version":"4.1.0"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1097\/wco.0b013e328328f276","type":"journal-article","created":{"date-parts":[[2009,5,21]],"date-time":"2009-05-21T07:18:20Z","timestamp":1242890300000},"page":"144-149","source":"Crossref","is-referenced-by-count":43,"title":["Genetic basis for idiosyncratic reactions to antiepileptic drugs"],"prefix":"10.1097","volume":"22","author":[{"given":"Diego","family":"Franciotta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Kwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio","family":"Perucca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-6-20210206","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1111\/j.1528-1167.2007.01041.x","article-title":"Idiosyncratic adverse reactions to antiepileptic drugs","volume":"48","author":"Zaccara","year":"2007","journal-title":"Epilepsia"},{"key":"R2-6-20210206","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1136\/pgmj.75.889.680","article-title":"Concordance of primary generalised epilepsy and carbamazepine hypersensitivity in monozygotic twins","volume":"75","author":"Edwards","year":"1999","journal-title":"Postgrad Med"},{"key":"R3-6-20210206","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1212\/WNL.56.7.890","article-title":"TNF-\u03b1 promoter region gene polymorphisms in carbamazepine hypersensitive patients","volume":"56","author":"Pirmohamed","year":"2001","journal-title":"Neurology"},{"key":"R4-6-20210206","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/01.fpc.0000189800.88596.7a","article-title":"Serious carbamazepine-induced hypersensitivity reactions associated with the HSP70 gene cluster","volume":"16","author":"Alfirevic","year":"2006","journal-title":"Pharmacogenet Genomics"},{"key":"R5-6-20210206","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/428486a","article-title":"Medical genetics: a marker for Stevens-Johnson syndrome","volume":"428","author":"Chung","year":"2004","journal-title":"Nature"},{"key":"R6-6-20210206","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/01.fpc.0000199500.46842.4a","article-title":"Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions","volume":"16","author":"Hung","year":"2006","journal-title":"Pharmacogenet Genomics"},{"key":"R7-6-20210206","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1111\/j.1528-1167.2007.01022.x","article-title":"Association between HLA-B*1502 allele and antiepileptic drug-induced cutaneous reactions in Han Chinese","volume":"48","author":"Man","year":"2007","journal-title":"Epilepsia"},{"key":"R8-6-20210206","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1111\/j.1528-1167.2008.01719.x","article-title":"Carbamazepine and phenytoin induced Stevens-Johnson syndrome is associated with HLA-B*1502 allele in Thai population","volume":"49","author":"Locharernkul","year":"2008","journal-title":"Epilepsia"},{"key":"R9-6-20210206","doi-asserted-by":"crossref","first-page":"813","DOI":"10.2217\/14622416.7.6.813","article-title":"HLA-B locus in Caucasian patients with carbamazepine hypersensitivity","volume":"7","author":"Alfirevic","year":"2006","journal-title":"Pharmacogenomics"},{"key":"R10-6-20210206","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/sj.tpj.6500356","article-title":"A marker for Stevens-Johnson syndrome \u2026: ethnicity matters","volume":"6","author":"Lonjou","year":"2006","journal-title":"Pharmacogenomics J"},{"key":"R11-6-20210206","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/FPC.0b013e3282f3ef9c","article-title":"A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs","volume":"18","author":"Lonjou","year":"2008","journal-title":"Pharmacogenet Genomics"},{"key":"R12-6-20210206","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.2217\/14622416.9.11.1617","article-title":"HLA-B locus in Japanese patients with antiepileptics and allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"9","author":"Kaniwa","year":"2008","journal-title":"Pharmacogenomics"},{"key":"R13-6-20210206","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/ACI.0b013e3282370c5f","article-title":"Human leukocytes antigens and drug hypersensitivity","volume":"7","author":"Chung","year":"2007","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"R14-6-20210206","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.2217\/14622416.8.12.1661","article-title":"Investigation into the multidimensional genetic basis of drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"8","author":"Pirmohamed","year":"2007","journal-title":"Pharmacogenomics"},{"key":"R17-6-20210206","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1399-0039.2007.00982.x","article-title":"HLA-A, -B, -C, -DRB1 and -DQB1 alleles and haplotypes in the Kinh population in Vietnam","volume":"71","author":"Hoa","year":"2008","journal-title":"Tissue Antigens"},{"key":"R18-6-20210206","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.humimm.2007.01.005","article-title":"HLA haplotypes in Singapore: a study of mothers and their cord blood units","volume":"68","author":"Tang","year":"2007","journal-title":"Human Immunol"},{"key":"R19-6-20210206","first-page":"15","article-title":"Association of HLA-B*1502 allele and carbamazepine-induced severe adverse cutaneous drug reaction among Asians, a review","volume":"13","author":"Lim","year":"2008","journal-title":"Neurology Asia"},{"key":"R20-6-20210206","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.humimm.2008.05.001","article-title":"Balancing selection and heterogeneity across the classical human leukocyte antigen loci: a meta-analytic review of 497 population studies","volume":"69","author":"Solberg","year":"2008","journal-title":"Human Immunol"},{"key":"R21-6-20210206","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.2217\/14622416.9.10.1543","article-title":"Carbamazepine, HLA-B*1502 and risk of Stevens-Johnson syndrome and toxic epidermal necrolysis: US FDA recommendations","volume":"9","author":"Ferrell","year":"2008","journal-title":"Pharmacogenomics"},{"key":"R22-6-20210206","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2217\/17410541.2.3.225","article-title":"HLA-B genotyping to detect carbamazepine-induced Stevens-Johnson syndrome: implications for personalizing medicine","volume":"2","author":"Hung","year":"2005","journal-title":"Personalized Med"},{"key":"R25-6-20210206","doi-asserted-by":"crossref","first-page":"435","DOI":"10.2217\/14622416.8.5.435","article-title":"Glutathione S-transferase M1 null genotype as a risk factor for carbamazepine-induced mild hepatotoxicity","volume":"8","author":"Ueda","year":"2007","journal-title":"Pharmacogenomics"},{"key":"R26-6-20210206","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.cca.2007.11.035","article-title":"Glutathione S-transferase (GST) M1 null genotype and combined GSTM1 and GSTT1 null genotypes are risk factors for increased serum \u03b3-glutamyltransferase in valproic acid-treated patients","volume":"389","author":"Fukushima","year":"2008","journal-title":"Clin Chim Acta"},{"key":"R27-6-20210206","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1111\/j.1528-1157.1994.tb02546.x","article-title":"Severe hepatotoxicity during valproate therapy: an update and report of eight new fatalities","volume":"35","author":"K\u00f6nig","year":"1994","journal-title":"Epilepsia"},{"key":"R29-6-20210206","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1093\/brain\/awl088","article-title":"Phenotypic spectrum associated with mutations of the mitochondrial polymerase gamma gene","volume":"129","author":"Horvath","year":"2006","journal-title":"Brain"},{"key":"R30-6-20210206","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1093\/brain\/awl097","article-title":"The spectrum of clinical disease caused by the A467T and W748S POLG mutations: a study of 26 cases","volume":"129","author":"Tzoulis","year":"2006","journal-title":"Brain"},{"key":"R31-6-20210206","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1136\/adc.2007.122911","article-title":"Reversible valproate hepatotoxicity due to mutations in mitochondrial DNA polymerase gamma (POLG1)","volume":"93","author":"McFarland","year":"2008","journal-title":"Arch Dis Child"},{"key":"R32-6-20210206","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s11011-006-9039-9","article-title":"Valproic acid aggravates epilepsy due to MELAS in a patient with an A3243G mutation of mitochondrial DNA","volume":"22","author":"Lin","year":"2007","journal-title":"Metab Brain Dis"},{"key":"R33-6-20210206","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1212\/01.wnl.0000242882.58086.9a","article-title":"Brain pseudoatrophy and mental regression on valproate and a mitochondrial DNA mutation","volume":"67","author":"Galimberti","year":"2006","journal-title":"Neurology"},{"key":"R34-6-20210206","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/pbc.21149","article-title":"Translocation-positive acute myeloid leukemia associated with valproic acid therapy","volume":"50","author":"Williams","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"R35-6-20210206","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1111\/j.1528-1167.2007.01133.x","article-title":"Vigabatrin and epilepsy: lessons learned","volume":"48","author":"Wild","year":"2007","journal-title":"Epilepsia"},{"key":"R36-6-20210206","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.eplepsyres.2006.03.012","article-title":"A pharmacogenetic exploration of vigabatrin-induced visual field constriction","volume":"70","author":"Kinirons","year":"2006","journal-title":"Epilepsy Res"},{"key":"R37-6-20210206","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1600-0404.2007.00830.x","article-title":"Teratogenicity of antiepileptic drugs: role of drug metabolism and pharmacogenomics","volume":"116","author":"Sankar","year":"2007","journal-title":"Acta Neurol Scand"},{"key":"R38-6-20210206","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1056\/NEJM199005313222204","article-title":"Prenatal prediction of risk of the fetal hydantoin syndrome","volume":"322","author":"Buehler","year":"1990","journal-title":"N Engl J Med"},{"key":"R39-6-20210206","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1203\/PDR.0b013e3180a02e50","article-title":"Antiepileptic medication during pregnancy: does fetal genotype affect outcome?","volume":"62","author":"Atkinson","year":"2007","journal-title":"Pediatr Res"},{"key":"R40-6-20210206","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1093\/oxfordjournals.aje.a010290","article-title":"5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review","volume":"151","author":"Botto","year":"2000","journal-title":"Am J Epidemiol"},{"key":"R41-6-20210206","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1034\/j.1399-0004.1999.560306.x","article-title":"Fetal anticonvulsant syndrome and mutation in the maternal MTHFR gene","volume":"56","author":"Dean","year":"1999","journal-title":"Clin Genet"},{"key":"R42-6-20210206","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1002\/ajmg.a.31914","article-title":"Fetal anticonvulsant syndromes and polymorphisms in MTHFR, MTR, and MTRR","volume":"143A","author":"Dean","year":"2007","journal-title":"Am J Med Genet A"},{"key":"R43-6-20210206","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.seizure.2007.08.003","article-title":"A high frequency of the MTHFR 677C>T polymorphism in Scottish women with epilepsy: possible role in pathogenesis","volume":"17","author":"Dean","year":"2008","journal-title":"Seizure"},{"key":"R44-6-20210206","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.ejmg.2007.08.002","article-title":"Influence of the MTHFR genotype on the rate of malformations following exposure to antiepileptic drugs in utero","volume":"50","author":"Kini","year":"2007","journal-title":"Eur J Med Genet"}],"container-title":["Current Opinion in Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/WCO.0b013e328328f276","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:53:50Z","timestamp":1786038830000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00019052-200904000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/wco.0b013e328328f276","relation":{},"ISSN":["1350-7540"],"issn-type":[{"value":"1350-7540","type":"print"}],"subject":[],"published":{"date-parts":[[2009,4]]}}}